About Otsuka Pharmaceutical (Hong Kong)
Founded in 1921, the Otsuka Pharmaceutical Group began producing intravenous solutions in 1946 and established Otsuka Pharmaceutical Co., Ltd. (Otsuka Pharmaceutical) in 1964, solidifying its leadership in the field through nutritional therapies provided in clinical care. In 1971, Otsuka Pharmaceutical also began developing various pharmaceutical products. In addition, Otsuka Pharmaceutical applied the expertise and experience gained in the pharmaceutical manufacturing process to the development of consumer products. Today, Otsuka Pharmaceutical is widely recognized for its global leadership in pharmaceuticals, nutrition, and healthcare.
Otsuka Pharmaceutical (H.K.) Limited (Otsuka Hong Kong) was officially established in 1997. As a subsidiary of Otsuka Pharmaceutical Co., Ltd. Japan, Otsuka Hong Kong is primarily responsible for the marketing and sales of Otsuka Pharmaceutical Group products in Hong Kong and Macau.
With societal changes and economic development, the demand for healthcare products among Hong Kong people is rapidly increasing. Many Otsuka Pharmaceutical products have successfully entered the healthcare and pharmaceutical markets, making significant contributions to the health of Hong Kong people. These include renowned products such as POCARI SWEAT, Oronine H Ointment, Livact, Pletaal, and Abilify.






